THERAPY OF RECURRENT INVASIVE URINARY-TRACT INFECTIONS OF MEN

被引:58
作者
GLECKMAN, R [1 ]
CROWLEY, M [1 ]
NATSIOS, GA [1 ]
机构
[1] BOSTON UNIV,SCH MED,BOSTON,MA 02215
关键词
D O I
10.1056/NEJM197910183011607
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
THERE has been new interest in the therapy of urinary-tract infections, and new treatment programs have evolved.1,2 Men with recurrent urinary-tract infections present a formidable therapeutic challenge.3,4 Presumably short courses of antibiotic therapy fail to eradicate foci of infection that are frequently associated with structural abnormalities within the prostatic and renal parenchyma. We undertook a randomized, double-blind, placebo-controlled study to determine whether an extended course of therapy for men with recurrent, invasive urinary-tract infections would be more effective than the conventional two-week course of therapy. We found that a six-week course of antimicrobial therapy resulted in fewer relapses than the. © 1979, Massachusetts Medical Society. All rights reserved.
引用
收藏
页码:878 / 880
页数:3
相关论文
共 14 条
  • [1] Fang L., Tolkoff-Rubin N.E., Rubin R.H., Efficacy of single-dose and conventional amoxicillin therapy in urinary-tract infection localized by the antibody-coated bacteria technic, N Engl J Med, 298, pp. 413-416, (1978)
  • [2] Kallenius G., Winberg J., Urinary tract infections treated with single dose of short-acting sulphonamide, Br Med J, 1, pp. 1175-1176, (1979)
  • [3] Lindemeyer R.I., Turck M., Petersdorf R.G., Factors determining the out-come of chemotherapy in infections of the urinary tract, Ann Intern Med, 58, pp. 201-216, (1963)
  • [4] McCabe W.R., Jackson G.G., Treatment of pyelonephritis: bacterial, drug and host factors in success or failure among 252 patients, N Engl J Med, 272, pp. 1037-1044, (1965)
  • [5] Brenner D.J., Farmer J.J., Hickman F.W., Taxonomic and Nomenclature Changes in Enterobacteriaceae, pp. 1-15, (1977)
  • [6] Thomas V., Shelokov A., Forland M., Antibody-coated bacteria in the urine and the site of urinary-tract infection, N Engl J Med, 290, pp. 588-590, (1974)
  • [7] Harding G., Marrie T.J., Ronald A.R., Et al., Urinary tract infection localization in women, JAMA, 240, pp. 1147-1150, (1978)
  • [8] Guidelines for Protocols of New Antimicrobial Efficacy in Urinary Tract Infections, (1975)
  • [9] Smith C.R., Baughman K.L., Edwards C.Q., Et al., Controlled comparison of amikacin and gentamicin, N Engl J Med, 296, pp. 349-353, (1977)
  • [10] Turck M., Petersdorf R.G., Optimal duration of treatment of chronic urinary tract infection, Ann Intern Med, 69, pp. 837-839, (1968)